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Abstract 
Balo’s disease also known as Balo’s concentric sclerosis (BCS) is a rare demyelinating disorder 
which is characterized pathologically and radiologically by concentric rings of demyelinated 
and relatively myelin-preserved white matter. We describe the case of a 25-year-old female 
presenting with stroke-like symptoms who was diagnosed with BCS on MRI. At clinical onset, 
she also showed co-existing multiple sclerosis (MS)-typical lesions in the brain. This report 
extends the recent concept that BCS may share similar pathogenesis and radiological pro-
gression as MS lesions, that they may occur simultaneously in the same patient and that they 
may represent different manifestations of the same disease process. Also, BCS needs not be a 
fulminant disease and may often show a benign self-limiting course as in our case. 
© 2015 S. Karger AG, Basel 
Introduction 
Balo’s concentric sclerosis (BCS) is a rare demyelinating disease that was first described 
by the Hungarian neuropathologist Josef Balo in 1928. The initial terminology of this entity 
was ‘leuko-encephalitis periaxialis concentrica’, which was derived from its definition as ‘a 
disease which destroys the white matter of the brain in concentric layers leaving the axis 
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cylinder intact’ [1]. Traditionally, the clinical course of BCS was considered to be similar to 
the Schilder’s or Marburg’s variant of multiple sclerosis (MS), which shows fulminant pro-
gression, often with a fatal outcome. However, recent literature states that BCS often follows 
a benign course with prolonged survival. Also, BCS and MS-like lesions are being increasing-
ly reported to occur simultaneously, indicating that they may represent a continuum of the 
same disease process [2–6]. Our case report corroborates both these observations. It sum-
marizes the pathology, clinical manifestations, imaging features and management strategies 
of BCS along with a brief literature review. 
Case Presentation 
A 25-year-old left-handed Caucasian female presented to the emergency department of 
our hospital with acute onset of dysarthria and slight right-arm weakness which she noticed 
upon waking up in the morning. She also complained of mild accompanying headache. She 
had no febrile illness prior to the onset of symptoms. Neurological examination was notable 
for moderate dysarthria, mild right facial palsy and bradydiadochokinesis of the right hand. 
MRI of the brain showed a well-circumscribed 2-cm sized concentric lamellar lesion in the 
left centrum semiovale. The lesion showed alternate bands of iso-/hypointensity on T1W 
images and alternate hypo-/hyperintensity on T2W/FLAIR images (fig. 1a, b). There was 
mild associated peri-lesional oedema. A concentric pattern of post-contrast enhancement 
was noted within the lesion (fig. 1c), and a rim of restricted diffusion was seen along the 
margins of the lesion. Imaging features were consistent with the diagnosis of BCS. Few 
smaller 3- to 5-mm sized ovoid T2/FLAIR hyperintense MS-like lesions were also noted in 
the peri-ventricular and subcortical white matter (fig. 1d). None of these smaller lesions 
showed restricted diffusion or post-contrast enhancement. MRI of the spine showed no evi-
dence of demyelinating lesions. Laboratory tests were normal for C-reactive protein, Lyme’s 
disease, syphilis, HIV, antineutrophil cytoplasmic antibodies and rheumatoid factor. Cere-
brospinal fluid (CSF) analysis showed less than 1 white blood cell per mm3 (normal range 0–
4/mm3), glucose 3.6 mmol/l (normal range 2.4–4.2 mmol/l), and total protein 217 mg/l 
(normal range 200–500 mg/l). The IgG index was 0.63 (pathological if >0.7), but oligoclonal 
bands were present in the CSF (not in the serum), indicative of intrathecal IgG synthesis. 
The patient was treated with high-dose (500 mg/day) oral methylprednisolone for 5 
consecutive days, after which her clinical symptoms improved remarkably. A follow-up MRI 
at 4 months showed a more concentric appearance of the Balo lesion with regression of pre-
viously noted peri-lesional oedema, restricted diffusion and post-contrast enhancement (fig. 
2). Because of the additional typical MS lesions on the MRI scan and the positive oligoclonal 
bands in the CSF, she was started on immunomodulatory medication with interferon beta-
1b. However, after 9 months of interferon treatment, she developed numbness in the right 
lower limb, which was suspicious of a MS relapse (i.e. dissemination in time). The third MRI 
(at 25 months) showed significant interval decrease in size of the Balo lesion and stable 
smaller MS lesions. She has had no more clinical episodes and is presently asymptomatic. 
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Discussion 
The clinical, imaging, pathological and immunogenetic studies on the different forms of 
MS and other central nervous system demyelinating diseases falling within the same spec-
trum are relatively recent [2–6]. BCS is now considered to lie within the spectrum of atypical 
idiopathic inflammatory demyelinating lesions (AIIDLs) [2–4], sharing an apparent basic 
pathological similarity to MS, with the exception of a concentric band-like pattern of demye-
lination [7, 8]. The pathogenesis of this histologically striking lamellar form of demyelination 
has generated much speculation. Moore et al. [7] suggest that the primary demyelinating 
activity begins at a central core usually around a venule. Although the triggering event is 
unknown, a centrifugal band of lymphocytes and cytokines spreads from this initial site. The 
demyelinating activity periodically fades, only to be rejuvenated by the next bolus of activat-
ing substances, leading to concentric demyelination and myelin preservation [7]. More re-
cently, Stadelmann et al. [8] have proposed that in BCS, inflammatory demyelination occurs 
due to hypoxia-like tissue injury. According to this model, there may be protective precondi-
tioning of oligodendrocytes in a band of immediately adjacent white matter which is at least 
partially protected from demyelination. The inflammatory process spreads onwards until it 
reaches the next region of susceptible oligodendrocytes. This results in the so-called ‘onion 
bulb’ appearance of bands of demyelination alternating with relatively myelin-preserved 
white matter [8]. Another report has recently described the presence of Notch 3 mutation 
associated with cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL) in a case of BCS. CADASIL is a cerebral arteriolar occlusive 
disease with pathognomonic granular deposits of aggregated Notch 3 extracellular domain 
in small vessel walls. This report supports the hypothesis that BCS may occur due to muta-
tions which affect the vascular smooth muscle, leading to hypoxia-like tissue injury [9]. 
BCS mainly occurs in young adults with an average age at onset of 34 years (range 3–62 
years). An interesting observation about the epidemiology of BCS is that there may be a pre-
dilection for individuals of South-East Asian ethnicity [5, 6, 10, 11]. In Chinese patients with 
MS, optic nerve and spinal cord lesions are known to show more marked necrosis, axonal 
loss and less astrogliosis as compared to Caucasians. These phenomena suggest that differ-
ent ethnic groups may show diverse patterns of defence to inflammatory insult, most likely 
due to population-based genetic susceptibility and environmental factors [6, 10, 11]. 
BCS lesions are commonly seen in the white matter of the cerebral hemispheres; how-
ever, they can also occur in the optic chiasm, cerebellum, brainstem and spinal cord [2–7, 9–
12]. The typical MRI findings associated with BCS consist of a whorled appearance on T1W, 
T2W and contrast-enhanced T1W images [2–6, 10, 11]. Restricted diffusion may be seen 
within the lesion [2, 4]. The spreading margin of active inflammation shows ring-like en-
hancement with a demyelinated ring located at the inner aspect and this process continues 
step by step in a centrifugal direction. This natural progression of BCS on MRI appears simi-
lar to the evolution of MS plaques, where the first detectable abnormality is focal increase in 
permeability of the blood-brain barrier seen as contrast-enhancement on MRI, followed by 
abnormal T2 signal within the enhancement representing demyelination [11]. 
Patients with BCS may present with acute or subacute symptoms depending on the loca-
tion of the lesion. The common clinical manifestations include headache, cognitive or behav-
ioural dysfunction, hemiparesis, ataxia, dysarthria, aphasia as well as seizures [2, 3, 5, 6, 9–
11]. These features may be interpreted clinically as acute disseminated encephalomyelitis, 
stroke, or a space-occupying lesion like neoplasm or abscess [2, 3, 6, 10]. The diagnosis of 
BCS is made by correlating the classical MRI features with the clinical and CSF findings. CSF 
studies often show a mononuclear inflammatory reaction, elevated proteins and occasionally 
47 
 
Case Rep Neurol 2015;7:44–50 
DOI: 10.1159/000380813 
 
© 2015 S. Karger AG, Basel 
www.karger.com/crn 
Purohit et al.: Balo’s Concentric Sclerosis with Acute Presentation and Co-Existing 
Multiple Sclerosis-Typical Lesions on MRI 
 
 
 
oligoclonal bands. At times, the concentric pattern on MRI may not be apparent early in the 
disease and the lesion may mimic acute disseminated encephalomyelitis, neoplasm or an 
abscess. A brain biopsy is of value in such cases [2–6, 9–11]. Histopathological investigation 
requires myelin staining to determine alternating concentric zones of demyelination [10]. 
Due to the lack of antemortem diagnosis prior to the advent of MRI, most earlier case 
reports of BCS described a fulminant monophasic clinical course resulting in death within 
few weeks to months. Recently however, an increasing number of cases are being described 
with a benign clinical course and prolonged survival and it seems very likely that these were 
misdiagnosed or missed before the advent of MRI [2–6, 10, 11]. In fact, BCS may show a 
more marked clinical improvement from the initial attack as compared to other forms of 
AIIDLs [3]. 
Similar to our case, there is an increasing number of reports describing the simultane-
ous occurrence of MS-like lesions and BCS [2–6]. Wallner-Blazek et al. [3] have reported that 
additional MS-typical lesions co-exist with AIIDLs in about 53% of cases. New MS-typical 
lesions can occur in 42% of cases. They also state that further clinical attacks occur more 
often in patients with co-existing MS lesions. Wang et al. [5] reported that during follow-up, 
the Balo-like lesions may either dissolve or eventually transform into MS-like lesions. BCS 
has also been described in the brainstem of a patient with neuromyelitis optica [12]. This 
has led to the interesting observation that an extensive loss of aquaporin-4 occurs in BCS 
similar to neuromyelitis optica [13]. 
As applied in our patient, the indicated therapy for BCS is similar to that used during 
acute MS attacks. Most clinicians recommend early high-dose corticosteroid treatment [5, 6, 
9–11, 14]. Most patients respond to 1,000 mg/day of methylprednisolone therapy for 5–7 
days. Immunomodulatory or disease-modifying therapy, with or without steroids, has also 
been described [15]. Plasmapheresis exchanges have been reported to aid in clinical recov-
ery [9]. However, data from randomized, controlled treatment trials are lacking, and so far it 
is unclear which approach is the most promising. 
It may be concluded that the outcome of BCS might be more benign than previously an-
ticipated, showing a favourable clinical course and response to disease-modifying treatment. 
BCS may have varied clinical manifestations; however, the pathognomonic MRI features help 
to clinch the diagnosis. Also, BCS may occur simultaneously with MS-like lesions or may her-
ald the onset of MS, indicating that, in certain patients, they seem to be different manifesta-
tions of the same disease rather than separate pathological entities. Future studies describ-
ing serial/longitudinal MR imaging patterns in patients with simultaneous BCS and MS-like 
lesions would help to better understand the natural progression of these entities. 
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Fig. 1. a Axial T1W MRI (baseline MRI) shows a 2 cm sized well-circumscribed hypointense lesion in the 
left centrum semiovale. b Corresponding axial T2W MRI shows ill-defined concentric bands within the 
lesion. There is minimal peri-lesional oedema. c Corresponding contrast-enhanced coronal T1W MRI 
shows concentric enhancement within the lesion, which is pathognomonic of BCS. d Corresponding axial 
FLAIR image shows the Balo lesion along with a simultaneous small ovoid hyperintense lesion in the left 
peri-trigonal white matter. These findings indicate associated MS. 
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Fig. 2. a Axial T2W MRI (follow-up MRI at 4 months) shows very well delineated concentric rings within 
the Balo lesion. No peri-lesional oedema is seen. b Corresponding contrast-enhanced axial T1W MRI 
shows interval regression of the previously noted contrast enhancement within the lesion. 
 
